A detailed history of Pallas Capital Advisors LLC transactions in Incyte Corp stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 38,000 shares of INCY stock, worth $2.66 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
38,000
Previous 43,766 13.17%
Holding current value
$2.66 Million
Previous $2.65 Million 2.38%
% of portfolio
0.11%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 09, 2025

SELL
$55.17 - $71.22 $318,110 - $410,654
-5,766 Reduced 13.17%
38,000 $2.59 Million
Q1 2025

Apr 14, 2025

BUY
$60.0 - $75.26 $1.75 Million - $2.2 Million
29,195 Added 200.36%
43,766 $2.65 Million
Q4 2024

Jan 13, 2025

BUY
$65.08 - $83.38 $948,280 - $1.21 Million
14,571 New
14,571 $1.01 Million
Q2 2024

Jul 19, 2024

BUY
$51.18 - $63.75 $164,083 - $204,382
3,206 New
3,206 $194,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Pallas Capital Advisors LLC Portfolio

Follow Pallas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.